Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07290751
Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke
Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke: A Multicenter, Prospective, Double-Blind, Placebo-Controlled, Randomized Controlled Trial
Sponsor: Beijing Anzhen Hospital
Conditions
Acute Ischemic Stroke
Interventions
Placebo (0.9% normal saline) Tirofiban
Updated 1 time since 2026 Last updated: Dec 22, 2025 Started: Nov 11, 2025 Primary completion: Oct 30, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Acute Ischemic Stroke, this trial is actively recruiting participants. The trial is conducted by Beijing Anzhen Hospital and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Beijing Anzhen Hospital
Data source: Beijing Anzhen Hospital
For direct contact, visit the study record on ClinicalTrials.gov .